Jpmorgan Chase & CO Inogen Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INGN
# of Institutions
136Shares Held
22MCall Options Held
122KPut Options Held
35.4K-
Divisadero Street Capital Management, LP Miami, FL2.35MShares$21.8 Million3.29% of portfolio
-
Camber Capital Management LP Boston, MA2MShares$18.5 Million0.45% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.95MShares$18.1 Million0.33% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$13.3 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $212M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...